CPTAC Assay Portal: a repository of targeted proteomic assays
To address these issues, the Clinical Proteomic Tumor Analysis Consortium (CPTAC) of the National Cancer Institute (NCI) has launched an Assay Portal (http://assays.cancer.gov) to serve as a public repository of well-characterized quantitative, MS-based, targeted proteomic assays. The purpose of the CPTAC Assay Portal is to facilitate widespread adoption of targeted MS assays by disseminating SOPs, reagents, and assay characterization data for highly characterized assays. A primary aim of the NCI-supported portal is to bring together clinicians or biologists and analytical chemists to answer hypothesis-driven questions using targeted, MS-based assays. Assay content is easily accessed through queries and filters, enabling investigators to find assays to proteins relevant to their areas of interest. Detailed characterization data are available for each assay, enabling researchers to evaluate assay performance prior to launching the assay in their own laboratory.
- Research Organization:
- Pacific Northwest National Lab. (PNNL), Richland, WA (United States). Environmental Molecular Sciences Lab. (EMSL)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- AC05-76RL01830
- OSTI ID:
- 1172461
- Report Number(s):
- PNNL-SA-103950; 46206; 400412000
- Journal Information:
- Nature Methods, 11(7):703-704, Journal Name: Nature Methods, 11(7):703-704
- Country of Publication:
- United States
- Language:
- English
Similar Records
Targeted proteomic assays for quantitation of proteins identified by proteogenomic analysis of ovarian cancer
Reproducibility of Differential Proteomic Technologies in CPTAC Fractionated Xenografts